References: Roberts ISD, Besarani D, Mason P, Turner G, Friend PJ, Newton R. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer. 2008;99(9):1383-1386. doi:10.1038/sj.bjc.6604711.
Liu S, Chaudry MR, Berrebi AA, et al. Polyomavirus replication and smoking are independent risk factors for bladder cancer after renal transplantation. Transplantation. 2017;101:1488-1494.
Tsaur I, Karalis A, Probst M, et al. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center. Cancer Sci. 2010;101(11):2430-2435.
Odetola OE, Isaila B, Pambuccian SE, Barkan GA. Unusual BK polyomavirus associated urologic malignancies in renal transplant recipients: report of two cases and review of the literature. Diagn Cytopathol. 2018;46:1050-1059. doi:10.1002/dc.24044.
Chu YH, Zhong W, Rehauer W, et al. Clinicopathological characterization of post renal transplantation associated urothelial carcinoma, single institutional experience. Am J Clin Pathol. 2020;153(3):303-314. doi:10.1093/ajcp/aqz167.
Borgogna C, Albertini S, Martuscelli L, et al. Evidence of BK polyoma virus infection in urothelial but not renal tumours from a single centre cohort of kidney transplant recipients. Viruses. 2021;13(1):56. doi:10.3390/v13010056.
Gaur L, Gupta A, Meena P, Shingada A, Gupta P, Rana DS. Bladder carcinoma associated with BK virus in a renal allograft recipient. Ind J Nephrol. 2019;29(2):135-139. doi:10.4103/ijn.IJN_434_17.
Wang HH, Lui KL, Chu SH, Tian YC, Lai PC, Chiang. BK virus infection in association with post-transplant urothelial carcinoma. Transplant Proc. 2009;41(1):165-166. doi:10.1016/j.transpproceed.2008.08.138.
Alexiev BA, Randhawa P, Vazquez Martel E, et al. BK virus associated urinary bladder carcinoma in transplant recipients: report of two cases, review of the literature and proposed pathological model. Hum Pathol. 2013;44(5):908-917. doi:10.1016/j.humpath.2012.09.019.
Hill P, Alvin J, Goodman D. High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection. NDT Plus. 2009;2:246-249. doi:10.1093/ndtplus/sfp025.
Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyoma virus as a causal transforming agent. Transplantation. 2002;73(12):1933-1936.
Prom A, Jorgenson M, Alagunsundaramoorthy, S, Parajuli S. Persistent BK polyomavirus DNAemia may warrant cystoscopy to rule out urological carcinoma: a case report and review of the literature. Transpl Infect Dis. 2020;22(5):e13316. doi:10.1111/tid.13316.
Bialasiewicz S, Cho Y, Rockett R, et al. Association of micropapillary urothelial carcinoma of the bladder and BK viuria in kidney transplant recipients. Transpl Infect Dis. 2013;15(3):283-289. doi:10.1111/tid.12072.
Swaniski D, Goral S. BK Virus infection: an update on diagnosis and treatment. Nephrol Dial Transpl. 2015;30:209-217. doi:10.1093/ndt/gfu023.
Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC. Polyomavirus disease in renal transplantation. Review of pathological findings and diagnostic methods. Hum Pathol. 2005;36:1245-1255.
Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH Jr, Johnson EM. Polyoma Virus infection is a prominent risk factor for bladder carcinoma in immunocompetant individuals. Diagn Cytopathol. 2006;34:201-203. doi:10.1002/dc.20429.
Baker SC, Mason AS, Slip RG, et al. Induction of APOBEC3 - mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer. Oncogene. 2022;41(15):2139-2151. doi:10.1038/s41388-022-02235-8.
Grippo PJ, Sandgreen EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 t-antigen transgenic mouse model. Am J Pathol. 2000;157(3):805-813.
Zeng Y, Sun J, Bao J, Zhu T. BK polyoma virus infection promotes growth and aggressiveness in bladder cancer. Virol J. 2020;11(17):139. doi:10.1186/s12985-020-01399-7.
Ekberg H, Tedesco-Silva H, Demirbas A, et al. ELITE-symphony study (2007) reduced exposure to calcinuerin inhibitors in renal transplantation. NEJM. 357:2562-2575. doi:10.1056/NEJMoa067411.
Renal Transplant Handbook for the Royal Infirmary of Edinburgh, Infection prophylaxis and treatment, BK virus. [Accessed 06/07/2023] Available from: https://edren.org/ren/handbook/transplant-handbook/infection-prophylaxis-and-treatment/bk-virus/.
Biardeau X, Chartier-Kastler E, Rouprêt M, Phé V. Risk of malignancy after augmentation cystoplasty: a systematic review. Neurourol Urodyn. 2015;35(6):675-682. doi:10.1002/nau.22775.
Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol. 2009;22:S96-S118. doi:10.1038/modpathol.2009.26.
Papadimitriou JC, Randhawa P, Hanssen Rinaldo C, Drachenbery CB, Alexiev B, Hirsch HH. BK polyomavirus infection and renourinary tumorigenesis. Am J Transplant. 2016;12:398-406.
WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours (5th ed.), WHO Classification of Tumours; 2022. ISBN-13 978-92-832-4512-4.
Sangoi AR, Beck AH, Amin MB, et al. Intraobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Path. 2010;34(9):1367-1376.
Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol. 2009;19:252-260.
Bertz S, Ensser A, Stoehr R, et al. Variant morphology and random chromosomal integration of BK polyomavirus in post-transplant urothelial carcinomas. Mod Pathol. 2020;33(7):1433-1442. doi:10.1038/s41379-020-0489-0.
Moens U, Van Ghelue M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci. 2007;64:1656-1678.
Wang Y, Liu S, Deng W. Viral integration in BK polyomavirus associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing. Oncogene. 2020;39:5734-5742.
Hu J, Luo H, Xu Y, et al. The prognostic significance of EIF3C gene during the tumorigenesis of prostate cancer. Cancer Invest. 2019;37(4-5):199-208. doi:10.1080/07357907.2019.1618322.
Wei H, Kamat A, Chen M, et al. Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin. PLoS One. 2012;7(6):e38533. doi:10.1371/journal.pone.0038533.
No Comments.